News (97)

GE Aerospace : Annual Shareholders Meeting - Presentation PU
Saint Gobain : Attestation - Corporate patronage and sponsorship PU
Saint Gobain : Attestation - Global amount of the ten highest remunerations PU
Saint-Gobain reaches unprecedented levels MT
Saint Gobain : signs a definitive agreement to acquire CSR Limited, establishing a leading position in light and sustainable construction in Australia PU
GE Announces Boards of Directors for Future Independent GE Vernova and GE Aerospace BU
Saint Gobain : Half Year Financial Report 2023 - PU
INTERVIEW - Benoît Bazin, Saint-Gobain CEO: Confident despite global economic challenges MT
Saint Gobain : signs a definitive agreement to acquire Building Products of Canada Corp. PU
Saint Gobain : Official convening notice, published in the French BALO dated April 5, 2023 PU
New Report: Promoting a Sustainable Future for China's Travel Industry; Accor, together with Trip.com Group and McKinsey, launches whitepaper on sustainable travel in China and sets out series of industry and consumer recommendations AQ
Compagnie de Saint Gobain : H1-2022 Results Presentation - PDF PU
Transcript : Accor SA, H1 2022 Earnings Call, Jul 28, 2022
Compagnie de Saint Gobain : Half Year Financial Report 2022 - PDF PU
Accor : continues to transform and simplify its structure by leveraging its leadership positions in the most buoyant hospitality markets and segments PU
Accor : Invitation 2022 First-half result PU
Accor : enters into exclusive negotiations on the sale of a 10.8% interest in Ennismore, the fastest growing lifestyle hospitality company PU
Compagnie de Saint Gobain : SAINT-GOBAIN REINFORCES ITS LEADERSHIP IN LIGHT AND SUSTAINABLE CONSTRUCTION IN NORTH AMERICA BY SIGNING A DEFINITIVE AGREEMENT TO ACQUIRE KAYCAN, TOP SIDING PLAYER IN CANADA PU
Accor : Post-AGM press release PU
Compagnie de Saint Gobain : Official convening notice, published in the French BALO dated March 30, 2022 PU
Accor: Full-Year 2021 Results: Significant rebound in activity confirmed in 2021 AQ
Accor : Présentation des résultats annuels 2021 (en anglais uniquement) PU
Accor : Invitation Full-Year 2021 Results PU
GCP APPLIED TECHNOLOGIES : SIGNS A DEFINITIVE AGREEMENT TO BE ACQUIRED BY SAINT-GOBAIN - Form 8-K PU
FII 5th Anniversary Brings Together 250+ Leaders to Invest in Humanity PR
Transcript : Compagnie de Saint-Gobain S.A. - Analyst/Investor Day
Questex’s International Hospitality Investment Forum (IHIF) successfully reconnects global leaders in the hospitality investment and development sector – for the first time in over 18 months GL
Saint Gobain : Half-Year  Financial Report 2021 - PDF PU
Accor : Conference call invitation PU
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome GL
Saint Gobain : announces the winners of the 16th edition of its “Multi Comfort” international student competition PU
Saint Gobain : New Executive Committee as of July 1st, 2021 PU
Saint Gobain : General Shareholders’ Meeting, June 3, 2021 PU
Accor : Acquisition Company announces the success of its private placement and listing on Euronext Paris PU
Accor : Press Release post AG PU
Gecina : Sets up an Advisory Committee BU
Accor : Availability of documents and information for the Combined Ordinary and Extraordinary Shareholders’ meeting of April 29, 2021 PU
Transcript : Compagnie de Saint-Gobain S.A., 2020 Earnings Call, Feb 26, 2021
Accor : Invitation Full-Year 2020 Results PU
ENGIE : Swiss Life Asset Managers France, ENGIE and Nexity complete the sale of the future ENGIE eco-campus PU
Accor : doubles down on lifestyle and enters into exclusive negotiations with Ennismore PU
Saint Gobain : sets out its CO2 roadmap towards carbon neutrality by 2050 PU
High-temperature, low carbon processes: the challenge for the new Canopée laboratory PU
SNGN Romgaz : Raport semestrial (S1-2020) si Situatii financiare la 30 iunie 2020 PU
Résultats semestriels 2020 : décryptage PU
123NextSee all

Companies (535)

T-MOBILE US 207 B $
Logo T-Mobile US

T-Mobile US, Inc. specializes in mobile telecommunication services. Sales break down by activity as follows: - mobile telecommunication services (80.5%): mobile telephone service, long-distance telephone service, data transmission, Internet access, direc ...

AT&T INC. 126 B $
Logo AT&T Inc.

AT&T Inc. is one of the leading American telecommunication operators. The activity is organized mainly around two areas: - mobile telephony; - fixed telephony and cable services: local and long-distance telephony services. The group also offers broadban ...

FERRARI N.V. 73 727 M $
Logo Ferrari N.V.

Ferrari N.V. is a holding company organized around 3 areas of activity: - manufacturing and sale of luxury sports vehicles (85.8% of net sales): 458 Italia, 488 GTB, 458 Spider, 488 Spider, F12 Berlinetta, 458 Speciale, 458 Speciale A, California T and F ...

BENO HOLDING AG 22 M $
Logo BENO Holding AG

Beno Holding AG is a Germany-based company engaged in real estate rental, development and operations business sector. The Company is focused on managing essential real estate objects economically. It offers capital-giving solutions for medium-sized, comme ...

T. ROWE PRICE GROUP INC. 25 657 M $
Logo T. Rowe Price Group Inc.

T. Rowe Price Group, Inc. is an investment management company that provides investment advisory services to individual and institutional investors, retirement plans, and financial intermediaries. The group manages a broad range of American and internation ...

ALNYLAM PHARMACEUTICALS, INC. 20 288 M $
Logo Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...

TELSTRA GROUP LIMITED 26 710 M $
Logo Telstra Group Limited

Telstra Group Limited is an Australia-based telecommunications and technology company, offering a full range of communications services. The Company’s segments include Telstra Consumer and Small Business (TC&SB), Telstra Enterprise (TE), Networks, IT an ...

CHOW TAI FOOK JEWELLERY GROUP LIMITED 11 021 M $
Logo Chow Tai Fook Jewellery Group Limited

Chow Tai Fook Jewellery Group Limited specializes in the design, manufacture and marketing of luxury jewelry in platinum, gold and precious stones (sapphire, diamond, ruby, etc.). The group offers necklaces, earrings, rings, bracelets, pendants, etc. (Cho ...

BENO TNR, INC. 72 M $
Logo BENO TNR, Inc.

Beno TNR Inc, formerly BenoHoldings Inc, is a Korea-based company engaged in the construction business. The Company engages in the development, design, and construction of awning systems and radiant heating and cooling systems in the interior construction ...

M&T BANK CORPORATION 23 723 M $
Logo M&T Bank Corporation

M&T Bank Corporation is a banking group organized around 7 business sectors: - retail banking (29.4% of net interest income): sales of standard and specialized banking products and services (leasing, factoring, insurance, etc.); - commercial banking (22 ...

LULULEMON ATHLETICA INC. 38 252 M $
Logo lululemon athletica Inc.

lululemon athletica Inc. specializes in the design and marketing of technical sportswear for men and women. The group offers pants, t-shirts, shorts, jerseys, jackets, etc. as well as accessories (socks, shoes, rugs, bags, water bottles, etc.). Net sales ...

SAMSUNG C&T CORPORATION 15 516 M $
Logo Samsung C&T Corporation

Samsung C&T Corp is a Korea-based company principally engaged in the trading of industrial goods. The Company operates its business through six segments. The Trading segment is mainly engaged in the trading of chemicals, steel, natural materials, and livi ...

BIONTECH SE 22 221 M $
Logo BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...

KEURIG DR PEPPER INC. 46 144 M $
Logo Keurig Dr Pepper Inc.

Keurig Dr Pepper Inc. is is a leading producer of non-alcoholic beverages in North America. The group markets hot drinks, soft drinks, flavoured water, fruit juices, concentrated and syrups. Net sales break down by family of products as follows: - refres ...

T&D HOLDINGS INC. 8 876 M $
Logo T&D Holdings Inc.

T&D Holdings, Inc. is a holding company detaining shares in the life insurance companies Taiyo Life, Daido Life and T&D Financial Life. ...

LEGEND BIOTECH CORPORATION 7 738 M $
Logo Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...

TRUWORTHS LIMITED - $
Logo Truworths Limited

Truworths Limited specializes in the design, manufacturing and marketing of clothes and accessories for men and women. Net sales break down by activity as follows: - retail distribution of clothes and accessories (98.6%): Nine West, Guess, Ka'yanda, Bert ...

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 5 403 M $
Logo GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicine ...

HLA GROUP CORP., LTD. 6 242 M $
Logo Hla Group Corp., Ltd.

HLA GROUP CORP LTD, formerly Hla Corp Ltd, is a China-based company, principally engaged in the operation of branded garments, and the production and sales of high-end suits and business wear. The operations of branded garments include the management of b ...

BAIC BLUEPARK NEW ENERGY TECHNOLOGY CO.,LTD. 5 608 M $
Logo BAIC BluePark New Energy Technology Co.,Ltd.

BAIC BluePark New Energy Technology Co Ltd is a China-based company mainly engaged in the research, development, design, manufacturing, sales and service of pure electric passenger vehicles. The Company mainly owns the two brands of Jihu and BEIJING. Its ...

J&T GLOBAL EXPRESS LIMITED 9 025 M $
Logo J&T Global Express Limited

J&T Global Express Ltd is a China-based company principally engaged in global logistics services. The Company's businesses include express delivery services, cross-border logistics services, sales accessories and other services. The express delivery servi ...

VALMONT INDUSTRIES, INC. 5 502 M $
Logo Valmont Industries, Inc.

Valmont Industries, Inc. is a manufacturer of products and services for infrastructure and agricultural markets. The Company operates through two segments: Infrastructure and Agriculture. The Infrastructure segment consists of the manufacture and distribu ...

L&T TECHNOLOGY SERVICES LIMITED 6 139 M $
Logo L&T Technology Services Limited

L&T Technology Services Limited is an India-based engineering research and development (ER&D) services provider. The Company offers consultancy, design, development and testing services across the product and process development life cycle. The Company op ...

LI NING COMPANY LIMITED 6 115 M $
Logo Li Ning Company Limited

Li Ning Company Limited is specialized in designing, manufacturing and marketing clothing, shoes and sports equipment. The group offers products under its own brand (LI-NING) and licensed brands (Double Happiness, AIGLE, Danskin, Kason and Lotto). Net sal ...

FIVE BELOW, INC. 6 216 M $
Logo Five Below, Inc.

Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...

MEDIGENE AG 40 M $
Logo Medigene AG

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-bas ...

GILDAN ACTIVEWEAR INC. 6 328 M $
Logo Gildan Activewear Inc.

Gildan Activewear Inc. is a vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and hosiery products. Its primary product categories include activewear tops and bottoms (activewear), socks (hosiery), and underwea ...

THAI SUGAR TERMINAL 151 M $
Logo Thai Sugar Terminal

TSTE Public Company Limited, formerly Thai Sugar Terminal Public Company Limited, is a Thailand-based company, which is a provider of logistics services. It operates businesses relating to transfer and transportation services for sugar and certain agricul ...

AUTOLUS THERAPEUTICS PLC 1 197 M $
Logo Autolus Therapeutics plc

Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using ...

CUROCELL INC. 307 M $
Logo Curocell Inc.

Curocell Inc is a Korea-based company principally engaged in the manufacture, research and development (R&D) of drugs. The Company is also engaged in the development of novel chimeric antigen receptor (CAR)-T therapy technologies targeting novel cancer an ...

TC BIOPHARM (HOLDINGS) PLC 5 M $
Logo TC Biopharm (Holdings) Plc

TC BioPharm Limited is a clinical-stage cell therapy company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infecti ...

CERO THERAPEUTICS HOLDINGS, INC. 6 M $
Logo CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable cha ...

ATARA BIOTHERAPEUTICS, INC. 62 M $
Logo Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with s ...

LUX INDUSTRIES LIMITED 527 M $
Logo Lux Industries Limited

Lux Industries Limited is an India-based company, which is primarily engaged in the business of manufacturing knitted garments. The Company's products include men's, women's and kids' innerwear, winterwear, socks and slacks for women in varied colors and ...

ADAPTIMMUNE THERAPEUTICS PLC 258 M $
Logo Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy ca ...

TSCAN THERAPEUTICS, INC. 444 M $
Logo TScan Therapeutics, Inc.

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company’s lead TCR-T therapy c ...

CYTOMED THERAPEUTICS LIMITED 22 M $
Logo CytoMed Therapeutics Limited

CytoMed Therapeutics Limited is a pre-clinical biopharmaceutical company. The Company is focused on harnessing its licensed proprietary technologies to create cell-based immunotherapies for the treatment of human cancers. The development of its technologi ...

MUSTANG BIO, INC. 4 M $
Logo Mustang Bio, Inc.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to adva ...

KALTURA, INC. 179 M $
Logo Kaltura, Inc.

Kaltura, Inc. is a video technology provider. The Company's segments include Enterprise, Education, and Technology (EE&T) and Media and Telecom (M&T). The EE&T segment represents products related to industry solutions for education customers, and media se ...

MAGYAR TELEKOM TÁVKÖZLÉSI NYILVÁNOSAN MÜKÖDÖ RÉSZVÉNYTÁRSASÁG 2 573 M $
Logo Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság

Magyar Telekom Tavkozlesi Nyrt is engaged in providing fixed line and mobile telecommunication services for public and business customers. The Company's segments include Telekom Hungary, T-Systems, Macedonia and Montenegro. Its Telekom Hungary segment ope ...

GRACELL BIOTECHNOLOGIES INC. 991 M $
Logo Gracell Biotechnologies Inc.

Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric ant ...

T&R BIOFAB CO., LTD. 100 M $
Logo T&R Biofab Co., Ltd.

T&R Biofab Co., Ltd. is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production ...

SNT HOLDINGS CO., LTD. 233 M $
Logo SNT Holdings Co., Ltd.

SNT Holdings Co Ltd, formerly S&T Holdings Co Ltd, is a Korea-based holding company engaged in the management of its subsidiaries. Through its subsidiaries, the Company operates in four business divisions: automobile parts division, which manufactures axl ...

RECTIFIER TECHNOLOGIES LIMITED 8 M $
Logo Rectifier Technologies Limited

Rectifier Technologies Limited is an Australia-based company, which designs and manufactures high-efficiency power rectifiers and produces electronic and specialized magnetic components. The Company's segments include Electronic Components, Industrial Pow ...

SNT ENERGY CO., LTD. 142 M $
Logo SNT Energy Co., Ltd.

SNTEnergy Co Ltd, formerly S&T Corp, is a Korea-based company engaged in the manufacture and sale of heat exchangers. The Company manufactures heat exchangers, which are used for petrochemical plants, oil refining plants, gas plants and others; heat recov ...

ANIXA BIOSCIENCES, INC. 84 M $
Logo Anixa Biosciences, Inc.

Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs in ...

IN8BIO, INC. 48 M $
Logo IN8bio, Inc.

IN8bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T c ...

ADICET BIO, INC. 111 M $
Logo Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead produc ...

NCR ATLEOS CORPORATION 2 047 M $
Logo NCR Atleos Corporation

NCR Atleos Corporation is a financial technology company providing self-directed banking solutions to a global customer base, including financial institutions, merchants, manufacturers, retailers and consumers. The Company's solutions enable the accelerat ...

GUOBO ELECTRONICS CO., LTD. 3 979 M $
Logo Guobo Electronics Co., Ltd.

Guobo Electronics Co Ltd is a China-based company mainly engaged in the research and development, production and sales of active phased array transmitter and receiver (T/R) components and radio frequency integrated circuits related products. The Company's ...

ALLOGENE THERAPEUTICS, INC. 491 M $
Logo Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on four core p ...

MARKER THERAPEUTICS, INC. 37 M $
Logo Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It h ...

CONNECT BIOPHARMA HOLDINGS LIMITED 88 M $
Logo Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company focused on improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. It is building ...

IMUGENE LIMITED 281 M $
Logo Imugene Limited

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to ha ...

CARGO THERAPEUTICS, INC. 658 M $
Logo CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chime ...

CELYAD ONCOLOGY SA 13 M $
Logo Celyad Oncology SA

Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprie ...

INTERNATIONAL KNITWEAR LIMITED 502 629 $
Logo International Knitwear Limited

International Knitwear Limited is a Pakistan-based company that is engaged in creating, developing and manufacturing knitted and woven apparel products. The Company is also engaged in the export of garments. Its product categories include men's wear, ladi ...

CABALETTA BIO, INC. 515 M $
Logo Cabaletta Bio, Inc.

Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administra ...

KYVERNA THERAPEUTICS, INC. 411 M $
Logo Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. is a patient-centered, clinical-stage biopharmaceutical company. The Company is focused on developing cell therapies for patients suffering from autoimmune diseases. The Company's lead program, KYV-101, is an autologous CD19 CAR ...

MAFIA TRENDS LIMITED 822 080 $
Logo Mafia Trends Limited

Mafia Trends Limited is an India-based company that is engaged in the business of trading of apparels and readymade garments. The Company is involved in the business of marketing and selling of men's fashion, which includes apparels such as jeans, t-shirt ...

M&T 1997, 17 M $
Logo M&T 1997,

M&T 1997 as is a Czech Republic-based company primarily engaged in appliances, tools and housewares business industry. The Company is a producer and designer of various sizes and shapes, brass handles, door fittings and window fittings under the M & T bra ...

SANU GOLD CORP. 8 M $
Logo Sanu Gold Corp.

Sanu Gold Corp. is a Canada-based junior mineral exploration-stage company. The Company is exploring three gold exploration permits. Its projects include Bantabaye, Daina and Diguifara. The Bantabaye is located within the Siguiri Basin, approximately 70 k ...

GARMENT MANTRA LIFESTYLE LIMITED 8 M $
Logo Garment Mantra Lifestyle Limited

Garment Mantra Lifestyle Limited is an India-based company engaged in the business of manufacturing, selling and distribution of fabrics, hosiery garments and providing related services. The Company offer a range of fabric types and can apply coatings or ...

VIRAX BIOLABS GROUP LIMITED 4 M $
Logo Virax Biolabs Group Limited

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling ...

THAI ENERGY STORAGE TECHNOLOGY 113 M $
Logo Thai Energy Storage Technology

Thai Energy Storage Technology PCL is a Thailand-based company, which is engaged in the manufacturing and distribution of batteries. The Company’s product categories include automotive battery, traction battery, EB battery, lighting battery, and golf ca ...

IMMUNOTECH BIOPHARM LTD 217 M $
Logo Immunotech Biopharm Ltd

Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR ...

PDS BIOTECHNOLOGY CORPORATION 102 M $
Logo PDS Biotechnology Corporation

PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused ant ...

CORVUS PHARMACEUTICALS, INC. 128 M $
Logo Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitini ...

2SEVENTY BIO, INC. 203 M $
Logo 2seventy bio, Inc.

2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). ...

T&G GLOBAL LIMITED 136 M $
Logo T&G Global Limited

T&G Global Limited is a grower, distributor, marketer and exporter of fresh produce, which includes apples, berries, citrus (lemons, mandarins and navel oranges) and tomatoes. The Company's segments include Apples, International Trading, T&G Fresh, Ventur ...

CARSGEN THERAPEUTICS HOLDINGS LIMITED 453 M $
Logo CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies. The Company’s therapies are applied in the trea ...

PRESCIENT THERAPEUTICS LIMITED 23 M $
Logo Prescient Therapeutics Limited

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, ...

CYTOMX THERAPEUTICS, INC. 108 M $
Logo CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and be ...

SANA BIOTECHNOLOGY, INC. 1 347 M $
Logo Sana Biotechnology, Inc.

Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, incl ...

ALLOVIR, INC. 86 M $
Logo AlloVir, Inc.

AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms l ...

KINETA, INC. 6 M $
Logo Kineta, Inc.

Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resista ...

ELICERA THERAPEUTICS AB 4 M $
Logo Elicera Therapeutics AB

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The Company is developing next-generation cell and gene therapies for immune-based treatment of cancer. The company is developing four drug candidates, two of which are in t ...

LYELL IMMUNOPHARMA, INC. 602 M $
Logo Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. is a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors. The Company is engaged in enrolling a Phase I clinical trial evaluating a ROR1-targeted CAR T-cell the ...

CHIMERIC THERAPEUTICS LIMITED 10 M $
Logo Chimeric Therapeutics Limited

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. I ...

INSTIL BIO, INC. 68 M $
Logo Instil Bio, Inc.

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first ...

CARTESIAN THERAPEUTICS, INC. 486 M $
Logo Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platfo ...

NEXIMMUNE, INC. 4 M $
Logo NexImmune, Inc.

NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates inc ...

IMMUTEP LIMITED 386 M $
Logo Immutep Limited

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or ...

TRIMURTHI LIMITED 2 M $
Logo Trimurthi Limited

Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Servic ...

VIGENCELL INC. 54 M $
Logo ViGenCell Inc.

ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In additi ...

CELL SOURCE, INC. 32 815 $
Logo Cell Source, Inc.

Cell Source, Inc. is a cell therapy company focused on immunotherapy. The Company is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management ...

ALX ONCOLOGY HOLDINGS INC. 419 M $
Logo ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint inhibitor and bridge the innate and adaptive immune system. Its product candidate ...

SHINE-ON BIOMEDICAL CO.,LTD. 101 M $
Logo Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody ...

FOXTRON VEHICLE TECHNOLOGIES CO., LTD. 2 405 M $
Logo Foxtron Vehicle Technologies Co., Ltd.

Foxtron Vehicle Technologies Co Ltd is a Taiwan-based company mainly engaged in the research and development of electric vehicle technology, the manufacture, management and sale of vehicle and component. The company's main products include an open platfor ...

TEVOGEN BIO HOLDINGS INC. 137 M $
Logo Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious ...

JANUX THERAPEUTICS, INC. 2 177 M $
Logo Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) ...

CUE BIOPHARMA, INC. 66 M $
Logo Cue Biopharma, Inc.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and b ...

CARIBOU BIOSCIENCES, INC. 162 M $
Logo Caribou Biosciences, Inc.

Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its gen ...

EUTILEX.CO.,LTD 53 M $
Logo Eutilex.Co.,Ltd

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies. ...

TELETOUCH COMMUNICATIONS, INC. 49 $
Logo Teletouch Communications, Inc.

Teletouch Communications, Inc. (Teletouch) offers a suite of telecommunications products and services, including cellular, two-way radio, global positioning system (GPS)-telemetry, wireless messaging and public safety equipment. The Company is an authoriz ...

POLTREG S.A. 52 M $
Logo Poltreg S.A.

Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm ...

ULTIMOVACS ASA 28 M $
Logo Ultimovacs ASA

Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacs’ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing ...

NOILE-IMMUNE BIOTECH INC. 51 M $
Logo Noile-Immune Biotech Inc.

Noile-Immune Biotech Inc is a Japan-based company mainly engaged in the development of chimeric antigen receptor T (CAR-T) cell therapy for solid tumors using proprietary technology. The Cancer Immunotherapy Drug Discovery Business segment develops variou ...

NEOIMMUNETECH, INC. 23 M $
Logo NeoImmuneTech, Inc.

NeoImmuneTech, Inc. is a clinical-stage T cell-focused biopharmaceutical company. The Company is engaged in the discovery and development of immuno-therapeutics. Its lead asset includes NT-I7 (efineptakin alfa), which is a T Cell Amplifier. NT-I7 is a hum ...

SUPER FINE KNITTERS LIMITED 2 M $
Logo Super Fine Knitters Limited

Super Fine Knitters Limited is an India-based company, which is engaged in the business of manufacturing knitted apparels/fabrics for itself as well as for national and international brands. The Company has a laboratory which is fully equipped for tests a ...


1234Next

Insiders

Sébastien Bazin
Sébastien Bazin

Mr. Sébastien M. Bazin is an Independent Director at General Electric Co., a Chairman at Théâtre du Châtelet, a Chairman & Chief Executive Officer at Accor SA, a Managing Director at Colony Europe, a Chairman at Bazeo Europe SAS, a Legal Manager at Rohan SARL, a Managing Partner at Bazeo Invest SNC, a Managing Partner at Haute Roche and a Managing Partner at Nina SCI. He is on the Board of Directors at General Electric Co., Huazhu Group Ltd. and Gustave Roussy Foundation. Mr. Bazin was previously employed as a Non-Independent Non-Executive Director by Banyan Tree Holdings Ltd., a Vice Chairman by Carrefour SA, an Independent Member-Supervisory Board by ANF Immobilier SA, a Chairman & President by Colony Capital SAS, a Chief Executive Officer by Colony Capital Europe, a Group Managing Director, CEO & General Manager by Société Immobilière & Hôtelière, a Chief Executive Officer by Hottinguer Rivaud Finances, a Vice Chairman-Supervisory Board by Buffalo Grill SAS, a Legal Manager by CC Europe Invest, a Partner by Ces Tenesol Réunion 2008, a Chairman by Château Lascombes SA, a Chairman by Coleven SAS, a Chairman by Colfilm SAS, a Chairman by Colillkirch France SAS, a Legal Manager by Colmassy SARL, a Legal Manager by Colmed, a Chairman & Chief Executive Officer by ColSpa SAS,


Picture Benoît Bazin
Benoît Bazin

Benoît Bazin is a French businessperson who has been at the helm of 13 different companies is Chief Operating Officer at Compagnie de Saint-Gobain SA and CEO-Saint Gobain Northern Europe at CTKC Corp. and on the board of 5 other companies. In the past Mr. Bazin occupied the position of Chairman for Saint-Gobain Distribution Batiment Suisse AG, Chairman-Supervisory Board of Point.P SAS, Chairman-Supervisory Board at Lapeyre SAS, Chairman-Supervisory Board for Saint-Gobain Weber France SAS, Chairman of Saint-Gobain Distribution Bâtiment France SAS, Chairman for Saint-Gobain Pam SA, Chairman of Saint Gobain Isover SA, Chairman at Partidis, Chairman for Saint-Gobain Distribution Nordic AB, Chairman of Projéo SA and President & Chief Executive Officer for CertainTeed Corp. He received an undergraduate degree from Ecole Polytechnique, an undergraduate degree from Ecole Nationale des Ponts et Chaussées, a graduate degree from Massachusetts Institute of Technology and an undergraduate degree from Sciences Po.





Picture Marc Bazin
Marc Bazin

Marc Bazin is the founder of HepatoChem, Inc., which was founded in 2008.
He holds the title of President at HepatoChem, Inc. starting in 2011.
Mr. Bazin's current job is at Princeton University, where he holds the title of Scientist.
Mr. Bazin's former job was at Pfizer Inc., where he held the title of Senior Scientist.
Mr. Bazin's education includes a graduate degree from Conservatoire National des Arts et Métiers.


Picture Emmanuel Bazin
Emmanuel Bazin

Emmanuel Bazin is currently a Director at 4D Global Energy Advisors SAS and Aladdin Middle East Ltd.
He is a graduate of Ecole Supérieure de Commerce de Rouen.







Picture Eric Bazin
Eric Bazin

Eric Bazin has a current job as the Head-Mechanical Snowmaking device at Téléverbier SA.


Picture Michèle Bazin
Michèle Bazin

Michèle Bazin has worked as the Vice President of Public Affairs at Conseil du Patronat du Quebec, Inc. since 2014.



Picture Raphaël Bazin
Raphaël Bazin

Raphaël Bazin is currently a Director at Bridgepoint SASU since 2021.
Prior to this, he worked as an Associate at Argos Wityu SAS from 2011 to 2017, a Finance Officer at PAI Partners SAS in 2010, and a Director at Amboise Partners SA.


Picture Pascal Bazin
Pascal Bazin

Pascal Bazin founded PB Consulting in 2012, where he worked as Chairman.
Mr. Bazin also currently works at Corlet Imprimeur SAS, as Managing Director and TV-Card SAS, as Production Manager.
Mr. Bazin also formerly worked at Avis Budget EMEA Ltd., as Chief Executive Officer from 2008 to 2011, LRUK (Holdings) Ltd., as CEO & Senior Vice President-Group Strategy, Avis Ltd., as Chief Executive Officer, Europcar Mobility Group SA, as Deputy Chairman-Supervisory Board from 2014 to 2021, Darty Ltd., as Independent Non-Executive Director from 2012 to 2016, Financière Brame SAS, as Director, Marie Brizard Wine & Spirits SA, as Non-Executive Director, D'IM SA (Luxembourg), as Director, Alcopa NV, as Director, Redcats SASU, as Managing Director-Specialised Brands Division from 2000 to 2005, Groupe Heppner SA, as Regional Director, Modacin France SAS, as Director, and Yves Rocher North America, Inc., as Managing Director from 1984 to 2000.
Mr. Bazin received his undergraduate degree from Ecole Polytechnique.








Picture Raphaël Bazin
Raphaël Bazin

Raphaël Bazin has worked as a Director at Apax Partners Development SA since 2019.


Picture Jean Bazin
Jean Bazin

Jean Bazin currently works at Sunrise Credit Union Ltd., as Director.




Picture Geoffroy Bazin
Geoffroy Bazin

Geoffroy Bazin is currently the Chairman at BNP Paribas Lease Group SA since 2018.
Prior to this, he held the position of Chief Executive Officer at BNP Paribas (Suisse) SA, and was also the Chairman at BGL BNP Paribas SA (Private Banking) and BGL BNP Paribas SA (Broker).
He was a Director at BGL BNP Paribas SA from 2010 to 2020.






Picture Bryan D. Bazin
Bryan D. Bazin

Mr. Bryan D.
Bazin
is a Director of Investment at Hume Capital Management Ltd.
He has over 23 years experience of running conservative fixed income portfolios for insurance companies and Lloyd's syndicates.
Prior to this, he served on the board at EPIC Asset Management Ltd.
Prior to joining EPAM (EPIC Asset Management), Mr. Bazin established a UK investment dealing desk for City Capital Counselling UK.
He was also a Senior Investment Manager with Whittingdale Limited before joining JR Butler Investment Management as Managing Director.
He remained a Director with its successor, Apsley Investment Management, where he was jointly responsible for all investment policy and the management of £1.6 billion.
Mr. Bazin has a masters degree in Economics.










Picture Jean C. R. Bazin
Jean C. R. Bazin

Jean C.
R.
Bazin
is currently the Chairman & President at SGF Rexfor, Inc. and serves as Counsel at both Specialty Technical Publishers, Inc. and Dentons Canada LLP.
He previously served as Chairman at B2B Bank, Director at Laurentian Bank of Canada, Director at 5N Plus, Inc., Director at Miranda Technologies, Inc., Director at Investissement Québec, Director at Bradley Air Services Ltd., Director at The Canadian Association of Former Parliamentarians, Counsel at Fraser Milner Casgrain LLP, President at The Canadian Bar Association, President at The Quebec-Japan Business Forum, and Member at The Senate of Canada.
Bazin received his undergraduate degree from Université Laval in 1964.




Picture Oliver Bazin
Oliver Bazin

Mr. Oliver Bazin, CFA, is a Deputy Fund Manager at GVQ Investment Management Ltd.
Prior to joining GVQIM in 2016 as an Analyst, he worked at Rothschild in their M&A practice.
He started his career at KPMG in their audit practice.
He holds both the ACA and CFA qualifications.


Picture Paul Bazin
Paul Bazin

Paul Bazin currently works at Daphni SAS, as Analyst from 2016.



Picture Pierre Bazin
Pierre Bazin

Pierre Bazin has a current job as a Director at La Cave des Hautes Cotes SC.








No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW